INDPVSRGC• 12 Months (Normalized)
INDP vs RGC (Indaptus Therapeutics Inc. vs Regencell Bioscience Holdings Limited)
Showing Closing Date Range from Sep, 15, 2025 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
INDP Performance $3.64
+59.65%
Indaptus Therapeutics Inc.
Normalized Baseline0.00%
RGC Performance $5.6
-60.98%
Regencell Bioscience Holdings Limited
Normalized Baseline0.00%
Alpha Spread Margin INDP LEADS
+120.63%
INDP outperforming by 120.63%
INDPRGC
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
INDP RGC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | INDP Price | INDP Gain (%) | RGC Price | RGC Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $3.64 | +59.65% | $5.60 | -60.98% | +120.63% |
| Sep 14, 2026 | $3.14 | +37.72% | $5.74 | -60.00% | +97.72% |
| Sep 11, 2026 | $2.77 | +21.49% | $5.64 | -60.70% | +82.19% |
| Sep 10, 2026 | $2.56 | +12.28% | $5.64 | -60.73% | +73.01% |
| Sep 09, 2026 | $2.08 | -8.77% | $5.85 | -59.23% | +50.46% |
| Sep 08, 2026 | $1.85 | -18.86% | $6.82 | -52.47% | +33.61% |
| Sep 04, 2026 | $1.22 | -46.49% | $6.89 | -51.99% | +5.50% |
| Sep 03, 2026 | $1.16 | -49.12% | $6.48 | -54.84% | +5.72% |
| Sep 02, 2026 | $1.17 | -48.68% | $6.31 | -56.03% | +7.35% |
| Sep 01, 2026 | $1.13 | -50.44% | $5.50 | -61.67% | +11.23% |
| Aug 31, 2026 | $1.15 | -49.78% | $5.51 | -61.60% | +11.82% |
| Aug 28, 2026 | $1.14 | -50.00% | $5.50 | -61.67% | +11.67% |
| Aug 27, 2026 | $1.16 | -49.12% | $5.52 | -61.53% | +12.41% |
| Aug 26, 2026 | $1.14 | -50.00% | $5.50 | -61.67% | +11.67% |
| Aug 25, 2026 | $1.10 | -51.97% | $5.54 | -61.39% | +9.42% |
Page 1 of 17